Press Releases

Predictmedix AI Achieves Significant Milestones in Mental Health Detection and Analysis

Dec 5, 2023 - Press Releases

Toronto, Ontario – December 5th, 2023 – Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI) is proud to announce ground-breaking achievements in the realm of mental health detection and analysis. With a commitment to advancing healthcare through […]

Predictmedix AI Announces Successful Clinical Validation at the University of Raharja, Indonesia, Demonstrating 95% Accuracy in Vital Sign Detection

Nov 14, 2023 - Press Releases

Toronto, Ontario – November 14, 2023 – Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI) is proud to announce the results of a clinical validation conducted in collaboration with the esteemed University of Raharja in Indonesia. Clinical […]

Predictmedix AI Unveils Safe Entry Stations to Delegates from 30 Nations at D-30 Event in New Delhi

Nov 6, 2023 - Press Releases

Toronto, Ontario – November 6, 2023 – Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI) is proud to announce that it introduced its state-of-the-art Safe Entry Stations to delegates from 30 countries during the D-30 event in […]

Predictmedix AI Showcases Innovative Impairment Screening Technology at a 30-Country Summit in India, Focusing on Combating Drug Addiction Globally

Nov 2, 2023 - Press Releases

Toronto, Ontario – November 2, 2023 – Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI) is proud to announce that it has been invited to the D-30 event to showcase its impairment screening technology, which is an […]

Predictmedix AI Accelerates Corporate Expansion During Month-Long International Campaign

Oct 27, 2023 - Press Releases

Toronto, Ontario – October 27, 2023 – Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”), has just returned from a fruitful month of international endeavors, during which the company achieved significant milestones in corporate development.   Throughout its overseas venture, Predictmedix AI has made remarkable strides, reinforcing its commitment to innovation […]

Predictmedix AI Executives Departing This Weekend for Strategic Collaborations in India

Sep 20, 2023 - Press Releases

Toronto, Ontario – September 20, 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) today announced that visas have been granted for a strategic visit to India. The primary purpose of the company’s executives’ visit is to engage with institutional partners and government officials in India, with a keen focus on […]

Predictmedix AI Showcased in Toronto Star Newspaper; Accelerates Oxygen Saturation Parameter to Accommodate Widespread Respiratory Health Issues

Sep 12, 2023 - Press Releases

Toronto, Ontario – September 12, 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) is proud to announce its recent feature in the prestigious Toronto Star newspaper, accompanied by a compelling interview with the company’s COO, Dr. Rahul Kushwah. This exciting development marks a significant milestone in Predictmedix’s journey, enhancing the […]

Predictmedix AI’s 2023 Breakthroughs: Pioneering Healthcare Innovation and Global Expansion

Sep 6, 2023 - Press Releases

Predictmedix AI’s 2023 Breakthroughs: Pioneering Healthcare Innovation and Global Expansion   Toronto, Ontario – September 6, 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) today provided an update on its achievements and developments so far in 2023. Predictmedix AI, a leader in AI-driven healthcare solutions, has achieved remarkable milestones and […]

Predictmedix AI Expands Diagnostic Reach in India with Innovative Diabetes Non-Invasive Screening

Aug 21, 2023 - Press Releases

Toronto, Ontario – August 21, 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) today announced a recent technological milestone in its AI product suite – the ability to detect early signs of diabetes in individuals by analyzing subtle biological indicators, often undetected by conventional methods. Predictmedix AI’s expansion into diabetic […]

Enhancing Healthcare Economics: Predictmedix AI’s Safe Entry Stations Revolutionize Safety and Efficiency

Aug 10, 2023 - Press Releases

Toronto, Ontario – August 10 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) today provided an update on its Safe Entry Stations as it relates to the healthcare vertical in which the company is rapidly commercializing into. Safe Entry was featured in an independent newspaper article in India focused on […]

Predictmedix AI Announces Milestone of Over 200,000 Individual Scans with AI-Powered Safe Entry Station

Aug 2, 2023 - Press Releases

Toronto, Ontario – August 2, 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) is pleased to announce a significant milestone, having completed over 200,000 individual scans through its AI-powered Safe Entry Stations covering various vitals such as body temperature, heart rate, respiration rate, body weight, HRV, fatigue, and impairment. This […]

Predictmedix AI Provides Update on Commercialization of Safe Entry with the Indonesian Healthcare Sector

Jul 28, 2023 - Press Releases

Toronto, Ontario, July 28, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA: 3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), is pleased to announce significant progress in its commercialization roadmap to integrate Safe Entry Stations (SES) into the Indonesian healthcare sector. Through a […]